Barclays raises Edgewell price target to $28
Barclays analyst Lauren Lieberman maintained an Equal-Weight rating on Edgewell Personal Care and raised the price target to $28 from $21.

*this image is generated using AI for illustrative purposes only.
Barclays analyst Lauren Lieberman has maintained an Equal-Weight rating on Edgewell Personal Care while increasing the stock's price target to $28 from the previous $21.
The adjustment reflects a revised valuation outlook for the company. Edgewell Personal Care is listed on the NYSE under the ticker symbol EPC.
Rating and Price Target Details
The following table outlines the updated rating and price target provided by Barclays:
| Metric | Details |
|---|---|
| Rating | Equal-Weight |
| Previous Price Target | $21 |
| New Price Target | $28 |
The Equal-Weight stance suggests that the stock is expected to perform in line with the broader market.
What specific factors drove Barclays to revise Edgewell's valuation outlook?
How might Edgewell's upcoming earnings report influence further analyst adjustments?
What market conditions could impact Edgewell's ability to meet the new price target?



























